Description
Kamagra Super Jelly
Kamagra Super Jelly is presented as a combination product containing sildenafil and dapoxetine. Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor, and dapoxetine is a short-acting serotonin reuptake inhibitor developed for premature ejaculation. The product name and strength should be treated as identification clues; combined products with this trade name are not established as standard regulatory medicines in the sources reviewed.
Active Ingredient and Medicine Class
Sildenafil belongs to the PDE5 inhibitor class. It is used in regulated medicines for erectile dysfunction and also in pulmonary arterial hypertension, depending on the product and label. Dapoxetine is a selective serotonin reuptake inhibitor designed for on-demand treatment of premature ejaculation.
Established Medical Uses
In the evidence reviewed, sildenafil is an established treatment for erectile dysfunction in approved products. Dapoxetine has been studied and authorised in some regions for premature ejaculation. Clinical trials have evaluated the combination of dapoxetine with sildenafil in men who have both premature ejaculation and erectile dysfunction, but this does not establish the combo as universally approved or standardised across markets.
How It Works
Sildenafil helps increase blood flow in the penis by enhancing the nitric oxide–cGMP pathway, which supports erection in response to sexual stimulation. Dapoxetine increases serotonin signalling and can delay ejaculation. Together, the two ingredients target different sexual function problems.
Important Safety Information
Sildenafil is contraindicated with nitrates or nitric oxide donors because of the risk of marked blood pressure lowering. It also requires caution with alpha-blockers and strong CYP3A4 inhibitors. Dapoxetine is contraindicated with monoamine oxidase inhibitors and should not be used with certain serotonergic medicines because of the risk of serotonin-related toxicity. Dapoxetine may also be unsuitable in people with a history of fainting, significant heart problems, or other conditions listed in official product information.
Possible Side Effects
Common adverse effects reported with these medicines include nausea, headache, dizziness, flushing, diarrhoea, palpitations, and postural dizziness. Sildenafil can also cause visual disturbances and, rarely, priapism or serious cardiovascular events. Dapoxetine studies have also reported syncope and mood-related adverse effects as important safety concerns to watch for.
Scientific Evidence
PubMed-indexed trials show that dapoxetine improves premature ejaculation outcomes, and combination studies with sildenafil suggest potential benefit in men who have both premature ejaculation and erectile dysfunction. However, the evidence base is limited, and most data come from relatively small or selected study populations rather than broad regulatory evaluations of this exact jelly formulation.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- FDA — REVATIO (sildenafil) Highlights of Prescribing Information
- EMA — Priligy: Summary of Product Characteristics / Package Leaflet
- Tuken M et al. — “Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study,” International Journal of Impotence Research, 2019. PubMed
